Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
Не применимо
Завершено
NCT03127722
| Заболевание | Contraception |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | Bayer |
|---|
| Статус | Завершено |
|---|
| Участники | 990 участн. |
|---|
| Вмешательство | Blood draw, ESSURE (BAY1454032), Laparoscopic tubal sterilization |
|---|
| Дата начала | 3.05.2017 |
|---|
| Дата завершения | 31.12.2024 |
|---|
| Публикация результатов | 22.05.2026 |
|---|
Кратко
This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization, including: * Pelvic and/or lower abdominal pain * Abnormal uterine bleeding * Surgical intervention (including "insert removal" and hysterectomy) * Allergic, hypersensitivity, or autoimmune-like reactions
Proportion of Subjects Reporting AEs of Chronic Lower Abdominal and/or Pelvic Pain After Insertion of Essure System or After Laparoscopic Tubal Sterilization
Up to 60 months · Participants
| ESSURE (BAY1454032) | 39 Participants |
|---|
| Laparoscopic Tubal Sterilization | 28 Participants |
|---|
Bleeding: The Proportion of Subjects Reporting AEs of Abnormal Uterine Bleeding (AUB) After Insertion of Essure System Compared to the Proportion of Subjects Reporting AEs of AUB After Laparoscopic Tubal Sterilization
Up to 60 months · Participants
| ESSURE (BAY1454032) | 59 Participants |
|---|
| Laparoscopic Tubal Sterilization | 57 Participants |
|---|
Proportion of Subjects With Reported Allergic/Hypersensitivity Reactions
Up to 60 months · Participants
| ESSURE (BAY1454032) | 6 Participants |
|---|
| Laparoscopic Tubal Sterilization | 3 Participants |
|---|
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.